Nyumbani › COPD › Alabama › Mobile
Majaribio ya kliniki ya COPD katika Mobile, AL
Masomo 4 ya COPD yanatafuta washiriki katika vituo vya Mobile na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.
Maandishi rasmi ya utafiti (Kiingereza)
Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
InaajiriHatua 3
- Research Site, Mobile
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
InaajiriHatua 3
- Pulmonary Associates - Mobile- Site Number : 8400151, Mobile
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
InaajiriHatua 3
- Research Site, Mobile
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
InaajiriHatua 2/3
- Pulmonary Associates of Mobile, P.C., Mobile
Majaribio ya COPD katika miji mingine
- Philadelphia, PAUtafiti 23
- Miami, FLUtafiti 18
- Birmingham, ALUtafiti 17
- Boston, MAUtafiti 17
- Houston, TXUtafiti 15
- Orlando, FLUtafiti 15
- Baltimore, MDUtafiti 14
- Chicago, ILUtafiti 14
- Dallas, TXUtafiti 12
- Pittsburgh, PAUtafiti 12
- New York City, NYUtafiti 11
- Ann Arbor, MIUtafiti 10
Masomo mengine katika Mobile
- Saratani ya Mapafu Isiyo na Selu NdogoUtafiti 13
- Kushindwa kwa MoyoUtafiti 13
- Saratan ya MapafuUtafiti 7
- Saratani ya MatitiUtafiti 7
- Kansari ya MayaiUtafiti 7
- UnenepuUtafiti 7
- Saratani (aina zote)Utafiti 6
- MelanomaUtafiti 6
- Saratan ya Mapafya ya Seli NdogoUtafiti 6
- Magonjwa ya Moyo na Mishipa ya DamuUtafiti 6
- Fibrillation ya AtriumUtafiti 5
- Uzito Kupita KiasiUtafiti 5
Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.